{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:49:27Z","timestamp":1794412167397,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the leading scientists Project of Jiangxi Science and Technology Department","award":["20213BCJL22050"],"award-info":[{"award-number":["20213BCJL22050"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860428"],"award-info":[{"award-number":["81860428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    \u201c\u201dWe employed radiomics and clinical features to develop and validate a preoperative prediction model to estimate the omental\u00a0metastases status of locally advanced gastric cancer (LAGC). A total of 460 patients (training cohort, n\u2009=\u2009250; test cohort, n\u2009=\u2009106; validation cohort, n\u2009=\u2009104) with LAGC who were confirmed T3\/T4 stage by postoperative pathology were continuously collected retrospectively, including clinical data and preoperative arterial phase computed tomography images (APCT). Dedicated radiomics prototype software was used to segment the lesions and extract features from the preoperative APCT images. The least absolute shrinkage and selection operator (LASSO) regression was used to select the extracted radiomics features, and a radiomics score model was constructed. Finally, a prediction model of omental metastases status and a nomogram were constructed combining the radiomics scores and selected clinical features. An area under the curve (AUC) of the receiver operating characteristic curve (ROC) was used to validate the capability of the prediction model and nomogram in the training cohort. Calibration curves and decision curve analysis (DCA) were used to evaluate the prediction model and nomogram. The prediction model was internally validated by the test cohort. In addition, 104 patients from another hospital's clinical and imaging data were gathered for external validation. In the training cohort, the combined prediction (CP) model (AUC 0.871, 95% CI 0.798\u20130.945) of the radiomics scores combined with\u00a0the clinical features, compared with clinical features prediction (CFP) model (AUC 0.795, 95% CI 0.710\u20130.879) and radiomics scores prediction (RSP) model (AUC 0.805, 95% CI 0.730\u20130.879), had the better predictive ability. The Hosmer\u2013Lemeshow test of the CP model showed that the prediction model did not deviate from the perfect fitting (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.893). In the DCA, the clinical net benefit of the CP model was higher than that of the CFP model and RSP model. In the test and validation cohorts, the AUC values of the CP model were 0.836 (95% CI 0.726\u20130.945) and 0.779 (95% CI 0.634\u20130.923), respectively. The preoperative APCT-based clinical-radiomics nomogram showed good performance in predicting omental metastases status in LAGC, which may contribute to clinical decision-making.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-35155-y","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T06:02:02Z","timestamp":1684994522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and validation of a CT radiomics and clinical feature model to predict omental metastases for locally advanced gastric cancer"],"prefix":"10.1038","volume":"13","author":[{"given":"Ahao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongfeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"issue":"3","key":"35155_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"17","key":"35155_CR2","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3748\/wjg.v25.i17.2029","volume":"25","author":"L Necula","year":"2019","unstructured":"Necula, L. et al. Recent advances in gastric cancer early diagnosis. World J. Gastroenterol. 25(17), 2029\u20132044 (2019).","journal-title":"World J. Gastroenterol."},{"key":"35155_CR3","doi-asserted-by":"crossref","unstructured":"Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 24(1), 1\u201321 (2021).","DOI":"10.1007\/s10120-020-01042-y"},{"issue":"2","key":"35155_CR4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.surg.2021.02.008","volume":"170","author":"WJ Seo","year":"2021","unstructured":"Seo, W. J. et al. Omentum preservation as an oncologically comparable and surgically superior alternative to total omentectomy during radical gastrectomy for T3\u2013T4 gastric cancer. Surgery. 170(2), 610\u2013616 (2021).","journal-title":"Surgery."},{"issue":"1","key":"35155_CR5","doi-asserted-by":"publisher","first-page":"16305","DOI":"10.1038\/s41598-020-73367-8","volume":"10","author":"Y Sakimura","year":"2020","unstructured":"Sakimura, Y., Inaki, N., Tsuji, T., Kadoya, S. & Bando, H. Long-term outcomes of omentum-preserving versus resecting gastrectomy for locally advanced gastric cancer with propensity score analysis. Sci. Rep. 10(1), 16305 (2020).","journal-title":"Sci. Rep."},{"issue":"11","key":"35155_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/jjco\/hyaa113","volume":"50","author":"Y Sato","year":"2020","unstructured":"Sato, Y. et al. Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC). Jpn. J. Clin. Oncol. 50(11), 1321\u20131324 (2020).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"12","key":"35155_CR7","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/bjs.11702","volume":"107","author":"M Ri","year":"2020","unstructured":"Ri, M. et al. Gastrectomy with or without omentectomy for cT3-4 gastric cancer: A multicentre cohort study. Br. J. Surg. 107(12), 1640\u20131647 (2020).","journal-title":"Br. J. Surg."},{"issue":"9","key":"35155_CR8","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1007\/s00464-022-09039-7","volume":"36","author":"S Lee","year":"2022","unstructured":"Lee, S. et al. Should total omentectomy be performed for advanced gastric cancer? The role of omentectomy during laparoscopic gastrectomy for advanced gastric cancer. Surg. Endosc. 36(9), 6937\u20136948 (2022).","journal-title":"Surg. Endosc."},{"issue":"7","key":"35155_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/lap.2019.0781","volume":"30","author":"S Olmi","year":"2020","unstructured":"Olmi, S. et al. Laparoscopic surgery of gastric cancer with D2 lymphadenectomy and omentum preservation: Our 10 years experience. J. Laparoendosc. Adv. Surg. Tech. A 30(7), 749\u2013758 (2020).","journal-title":"J. Laparoendosc. Adv. Surg. Tech. A"},{"issue":"1","key":"35155_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1186\/s12885-021-08672-0","volume":"21","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Prediction of serosal invasion in gastric cancer: Development and validation of multivariate models integrating preoperative clinicopathological features and radiographic findings based on late arterial phase CT images. BMC Cancer 21(1), 1038 (2021).","journal-title":"BMC Cancer"},{"issue":"6","key":"35155_CR11","doi-asserted-by":"publisher","first-page":"e1153","DOI":"10.1097\/SLA.0000000000003778","volume":"274","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y. et al. Development and validation of a deep learning CT signature to predict survival and chemotherapy benefit in gastric cancer: A multicenter retrospective study. Ann. Surg. 274(6), e1153\u2013e1161 (2021).","journal-title":"Ann. Surg."},{"issue":"2","key":"35155_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s00330-019-06398-z","volume":"30","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer. Eur. Radiol. 30(2), 976\u2013986 (2020).","journal-title":"Eur. Radiol."},{"issue":"1089","key":"35155_CR13","doi-asserted-by":"publisher","first-page":"20180259","DOI":"10.1259\/bjr.20180259","volume":"91","author":"Y Honma","year":"2018","unstructured":"Honma, Y. et al. Imaging peritoneal metastasis of gastric cancer with (18)F-fluorothymidine positron emission tomography\/computed tomography: a proof-of-concept study. Br. J. Radiol. 91(1089), 20180259 (2018).","journal-title":"Br. J. Radiol."},{"key":"35155_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12957-016-0790-z","volume":"14","author":"N Yamada","year":"2016","unstructured":"Yamada, N., Akai, A., Nomura, Y. & Tanaka, N. The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute. World J. Surg. Oncol. 14, 79 (2016).","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"35155_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: Images are more than pictures. They are data. Radiology 278(2), 563\u2013577 (2016).","journal-title":"Radiology"},{"issue":"4","key":"35155_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48(4), 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"35155_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1148\/radiol.2021200928","volume":"299","author":"M Ligero","year":"2021","unstructured":"Ligero, M. et al. A CT-based radiomics signature is associated with response to immune checkpoint inhibitors in advanced solid tumors. Radiology 299(1), 109\u2013119 (2021).","journal-title":"Radiology"},{"key":"35155_CR18","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts, H. J. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, 4006 (2014).","journal-title":"Nat. Commun."},{"issue":"1","key":"35155_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00330-019-06368-5","volume":"30","author":"S Liu","year":"2020","unstructured":"Liu, S. et al. Radiomics analysis using contrast-enhanced CT for preoperative prediction of occult peritoneal metastasis in advanced gastric cancer. Eur. Radiol. 30(1), 239\u2013246 (2020).","journal-title":"Eur. Radiol."},{"issue":"3","key":"35155_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194755","volume":"13","author":"HY Kim","year":"2018","unstructured":"Kim, H. Y. et al. Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?. PLoS ONE 13(3), e0194755 (2018).","journal-title":"PLoS ONE"},{"issue":"1","key":"35155_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1148\/radiol.13122697","volume":"269","author":"RA Gatenby","year":"2013","unstructured":"Gatenby, R. A., Grove, O. & Gillies, R. J. Quantitative imaging in cancer evolution and ecology. Radiology 269(1), 8\u201315 (2013).","journal-title":"Radiology"},{"issue":"12","key":"35155_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","volume":"2","author":"HJ Aerts","year":"2016","unstructured":"Aerts, H. J. The potential of radiomic-based phenotyping in precision medicine: A review. JAMA Oncol. 2(12), 1636\u20131642 (2016).","journal-title":"JAMA Oncol."},{"issue":"12","key":"35155_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: The bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14(12), 749\u2013762 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"35155_CR24","doi-asserted-by":"publisher","first-page":"2004503","DOI":"10.1183\/13993003.04503-2020","volume":"59","author":"J Schniering","year":"2022","unstructured":"Schniering, J. et al. Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis. Eur. Respir. J. 59(5), 2004503 (2022).","journal-title":"Eur. Respir. J."},{"issue":"18","key":"35155_CR25","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.3390\/cancers13184635","volume":"13","author":"D Santucci","year":"2021","unstructured":"Santucci, D. et al. The impact of tumor edema on T2-weighted 3T-MRI invasive breast cancer histological characterization: A pilot radiomics study. Cancers 13(18), 4635 (2021).","journal-title":"Cancers"},{"key":"35155_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.09.007","volume":"36","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine 36, 171\u2013182 (2018).","journal-title":"EBioMedicine"},{"issue":"18","key":"35155_CR27","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang, Y. Q. et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J. Clin. Oncol. 34(18), 2157\u20132164 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"35155_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun, R. et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: An imaging biomarker, retrospective multicohort study. Lancet Oncol. 19(9), 1180\u20131191 (2018).","journal-title":"Lancet Oncol."},{"issue":"6","key":"35155_CR29","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ejso.2020.11.132","volume":"47","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. CT-based radiomics nomogram for preoperative prediction of No.10 lymph nodes metastasis in advanced proximal gastric cancer. Eur. J. Surg. Oncol. 47(6), 1458\u20131465 (2021).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"35155_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.annonc.2020.04.003","volume":"31","author":"D Dong","year":"2020","unstructured":"Dong, D. et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: An international multicenter study. Ann. Oncol. 31(7), 912\u2013920 (2020).","journal-title":"Ann. Oncol."},{"issue":"8","key":"35155_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21143","volume":"4","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Development and validation of a computed tomography-based radiomics signature to predict response to neoadjuvant chemotherapy for locally advanced gastric cancer. JAMA Netw. Open 4(8), e2121143 (2021).","journal-title":"JAMA Netw. Open"},{"key":"35155_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.638362","volume":"11","author":"L Huang","year":"2021","unstructured":"Huang, L. et al. Computed tomography-based radiomics nomogram: Potential to predict local recurrence of gastric cancer after radical resection. Front. Oncol. 11, 638362 (2021).","journal-title":"Front. Oncol."},{"issue":"10","key":"35155_CR33","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/j.ejrad.2013.06.024","volume":"82","author":"A Ba-Ssalamah","year":"2013","unstructured":"Ba-Ssalamah, A. et al. Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur. J. Radiol. 82(10), e537-543 (2013).","journal-title":"Eur. J. Radiol."},{"issue":"12","key":"35155_CR34","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1007\/s00330-017-4881-1","volume":"27","author":"S Liu","year":"2017","unstructured":"Liu, S. et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers. Eur. Radiol. 27(12), 4951\u20134959 (2017).","journal-title":"Eur. Radiol."},{"issue":"4","key":"35155_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13167-019-00194-x","volume":"10","author":"S Qian","year":"2019","unstructured":"Qian, S., Golubnitschaja, O. & Zhan, X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 10(4), 365\u2013381 (2019).","journal-title":"EPMA J."},{"issue":"2","key":"35155_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.smim.2016.03.018","volume":"28","author":"K Moses","year":"2016","unstructured":"Moses, K. & Brandau, S. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells. Semin. Immunol. 28(2), 187\u2013196 (2016).","journal-title":"Semin. Immunol."},{"issue":"3","key":"35155_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.seminoncol.2014.04.003","volume":"41","author":"LA Coupland","year":"2014","unstructured":"Coupland, L. A. & Parish, C. R. Platelets, selectins, and the control of tumor metastasis. Semin. Oncol. 41(3), 422\u2013434 (2014).","journal-title":"Semin. Oncol."},{"issue":"13","key":"35155_CR38","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard, I. et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Can. Res. 69(13), 5383\u20135391 (2009).","journal-title":"Can. Res."},{"issue":"1","key":"35155_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2021.11.009","volume":"164","author":"K Njoku","year":"2022","unstructured":"Njoku, K., Ramchander, N. C., Wan, Y. L., Barr, C. E. & Crosbie, E. J. Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis. Gynecol. Oncol. 164(1), 146\u2013153 (2022).","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"35155_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100445","volume":"7","author":"M Stares","year":"2022","unstructured":"Stares, M. et al. Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer. ESMO Open. 7(2), 100445 (2022).","journal-title":"ESMO Open."},{"issue":"1","key":"35155_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10120-013-0259-5","volume":"17","author":"H Shimada","year":"2014","unstructured":"Shimada, H., Noie, T., Ohashi, M., Oba, K. & Takahashi, Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17(1), 26\u201333 (2014).","journal-title":"Gastric Cancer"},{"issue":"3","key":"35155_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4143\/crt.2004.36.3.178","volume":"36","author":"GI Hwang","year":"2004","unstructured":"Hwang, G. I. et al. Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma. Cancer Res. Treat. 36(3), 178\u2013181 (2004).","journal-title":"Cancer Res. Treat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35155-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35155-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T06:02:41Z","timestamp":1684994561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35155-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35155"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35155-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2368324\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8442"}}